je.st
news
SC high court further reduces penalty in drug marketing case
2015-07-08 19:22:31| Biotech - Topix.net
South Carolina's highest court has further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive drug marketing. In 2011, a trial court ordered the drug maker to pay $327 million, saying Janssen broke the law by downplaying to doctors the links between diabetes and Risperdal and by improperly claiming the drug was safer than competing medications.
Tags: high
case
marketing
court
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||